https://doi.org/10.13107/jocr.2023.v13.i09.3892
]]>PainRelief.io distribution partners attend the largest health show in Germany.
As one of the world's leading medical trade fairs, MEDICA in Düsseldorf presents innovations every year for the entire healthcare workflow, for clinical and outpatients. The event, is one of the most international attended trade fairs with 150 nations represented.
High-Tech topics like “The State of Digitalization” were discussed by Dr. Susanne Ozegowski, head of the department of "Digitalization and Innovation" at the Federal Ministry for Health.
Along with hundreds of interesting health sector innovations and novelties presented by seasoned companies and start-ups.
The PainRelief.io product fit right in with its novel approach to Drug-Free pain relief and was a topic of many discussions.
]]>Rhett Spencer attended the 4 day 2022 IASP World Congress on Pain which was held September 19-23 in Toronto, Canada.
The World Congress is the premier global multidisciplinary meeting on pain.
During the 4 day event Rhett demonstrated and answered questions from the 3,500 scientists, clinicians, and healthcare providers from 87 countries who were there in person.
The PainRelief.io product was well received and distributed to pain professionals in 52 of the 87 countries.
Rhett also met with government leaders and non-profit organizations to further the effort to help people in pain regardless of economic situations.
For more information contact rhett@painrelief.io
FIME July 27-29, 2022 Miami Beach Convention Center, USA
Anthony Sutera and Rhett Spencer will be demonstrating in person nCAP's patented novel pain relief technology.
They will be welcoming attendees to bring whatever pain they may have and experience in real time the fast acting relief the products provide.
Since 2012, nCAP pain relief technology has been helping millions of people around the world lessen their pain and muscle challenges.
Florida International Medical Expo is the Americas' leading medical trade fair and exhibition, gathering thousands of medical device and equipment manufacturers and suppliers, dealers, distributors and other healthcare professionals from across the United States, Central, South America and the Caribbean.
The show provides a platform to more than 700 exhibitors from over 45 countries, including country pavilions to showcase cutting edge device innovations and solutions.
nCAP will be stationed in the innovation section N21A
Desiree, Tony and Rhett at FIME 2022
]]>
The University of Pittsburgh and the Utah corporation nCAP Medical, a company involved in the development of pain relief devices, signed a contract to conduct “A Pilot Study Investigating the nCAP NeuroCuple(tm) in Subjects Undergoing Primary Hip Replacement Surgery
]]>
nCAP Medical will be attending Arab Health 2022 at the invitation of the World Trade Center as one of more than 3,500 exhibitors from over 60 countries across the world this January 24-27 in Dubai. The medical equipment exhibition will bring together more than 56,000 healthcare professionals - including government health care administrators and decision makers - to learn, network and trade. nCAP Medical will meet with multiple government healthcare officials from around the world in its continuing effort to reduce pain and the use of addicting pain relief products.
“We are honored and excited to present our products as part of the World Trade Center envoy,” says Rhett Spencer, co founder and Creator of Possible of nCAP Medical. “We believe our technology is changing the world of pain relief, and we feel enthusiastic about sharing it at such a global event.”
Since 2015, nCAP Medical has been using nanotechnology to create pain relief products that reduce or eliminate pain without the use of drugs, surgery or other often ineffective methods.
nCAP Medical will also be attending Medlab during the same time period to further develop strategic partnerships in the region.
]]>
Henry Ford's Invention Nation with Mo Rocca reports on the Kailo Patch and its origins.
]]>This white paper covers health statistics of chronic pain in the United States and the approach Signal Relief employs to reduce pain. It will discuss the novel product in the Signal Relief portfolio, the Signal Relief Patch, designed to greatly improve comfort in those experiencing pain.
You can find this study here.
]]>Clarity Science LLC has published a study of the Kailo patch in Anesthesia & Pain Research ISSN 2639-846X.
Using Nanotechnology to Improve Pain and Function with a Novel, Drug-Free, passive Pain-Relief Patch: An Interim Analysis,” represents preliminary outcomes from PREVENT (Pain Relief: Experience and Validity: Evaluating NanoTechnology), an IRB-approved, minimal risk, observational study.
Study can be found here
]]>nCAP Medical signed a licensing agreement with Caliber Med to further expand US Market's.
Caliber Med will utilize a variety of unique marketing techniques its developed from years in the direct-to-consumer space.
This additional marketing capability will enhance the reach of the technology, as more and more people discover the amazing pain relief the technology brings.
You can learn more about their products at signalrelief.com and meetjovi.com
The nCAP pain relief technology is a drug-free solution and easy to use, it's reusable and will work for years if taken care of and not misplaced.
]]>
nCAP Medical and Pain Relief Technologies sign a licensing agreement to expand the reach of nCAP's pain relief technology.
With this additional marketing capability it's hopeful that people around the world will discover the amazing relief the technology brings.
The nCAP pain relief technology is a drug-free solution and easy to use, it's reusable and will work for years if taken care of and not misplaced.
You can find this product at gokailo.com
"My employees and I are thrilled and grateful that we have a license to such an incredible technology from NCap Medical. The technology in the Kailo Pain Patch is a miracle of modern science and has the potential to change billions of lives. We do everything we can to make that happen."
Stuart Fetzer
Founder and CEO
Pain Relief Technologies
]]>OCTOBER 19, 2016
nCap Medical LLC announced it has accumulated anecdotal evidence that its non-invasive, Neurocuple(tm) technology has mitigated both acute and chronic pain without the need of opioids.
The Company’s teaming partner, the Sidra Academic and Research Hospital, will conduct random, double blind studies. The Academic Teaching Faculty WCMC supports the Institution: Qatar Ministry of Health and its other partner institutions at Education City, Qatar (Georgetown University, Carnegie Mellon University, Weill-Cornell Medicine in Qatar, college of the North Atlantic and HEC, Paris).
Dr. G. Russel Reiss, MD, Cardiothoracic Surgery, formerly at the University of Utah, commented, “If the studies of the nCap nano-technology based material reveal efficaciousness, this could have one of the most significant impacts on the practice of medicine and effectively address the misuse and abuse of opioids.”
Dr. Joseph Shumway, MD,MPH FACOG, Senior Consultant, Hamad Medical Corporation; Senior Attending Physician, Weill Cornell Medical College Academic Faculty, Qatar, will manage the study, and attempt to better understand the mechanism of action of the nCap material together with Dr. Arthur Penn Ramirez a physicist at the University of California, Santa Clara.
Dr. Shumway is a small, minority owner of a membership interest in nCap.
]]>